Cargando…
Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression
The development of gastric cancer is frequently related to the overexpression of wild-type p21 proteins, but it is rarely related to mutated Ras proteins. We previously constructed a broad-spectrum anti-p21-Ras single-chain variable fragment antibody (scFv), which was carried by the oncolytic adenov...
Autores principales: | Wang, Mingjuan, Hong, Yanling, Feng, Qiang, Pan, Xinyan, Song, Shuling, Cui, Jing, Lei, Jin, Fang, Hong, Yang, Julun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280635/ https://www.ncbi.nlm.nih.gov/pubmed/30534583 http://dx.doi.org/10.1016/j.omto.2018.10.003 |
Ejemplares similares
-
Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells
por: Liu, Fang-Rui, et al.
Publicado: (2018) -
Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide
por: Du, Yu, et al.
Publicado: (2021) -
BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor
por: Yu, Ting, et al.
Publicado: (2022) -
Cytokine-induced killer cells carrying recombinant oncolytic adenovirus expressing p21Ras scFv inhibited liver cancer
por: Dai, Fang, et al.
Publicado: (2021) -
Engineering a cell-penetrating hyperstable antibody scFv(Ras) – An extraordinary approach to cancer therapeutics
por: Bae, Jina, et al.
Publicado: (2021)